ČESKÁ UROLOGIE / CZECH UROLOGY – 1 / 2020

50 ORIGINÁLNÍ PRÁCE Ces Urol 2020; 24(1): 42–50 16. Pritchett TR, Moreno J, Warner NE, et al. Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder. J Urol 1988; 139(6): 1214–1216. 17. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. Jama 1994; 271(5): 368–374. 18. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical retro‑ pubic prostatectomy. Cancer 1993; 71(11): 3582–3593. 19. Epstein JI, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of pro‑ gression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol 1993; 149(6): 1478–1481. 20. Stamey TA, Freiha FS, McNeal JE, et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993; 71(3 Suppl): 933–938. 21. Bastian PJ, Mangold LA, Epstein JI, Partin AW. Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis. Cancer 2004; 101(9): 2001–2005. 22. Hekal IA, El‑Tabey NA, Nabeeh MA, et al. Validation of Epstein criteria of insignificant prostate cancer in Middle East patients. Int Urol Nephrol 2010; 42(3): 667–671. 23. Lee MC, Dong F, Stephenson AJ, et al. The Epstein criteria predict for organ‑confined but not insigni‑ ficant disease and a high likelihood of cure at radical prostatectomy. Eur Urol 2010; 58(1): 90–95. 24. Epstein JI, Allsbrook WC, Jr Amin MB, Egevad LL. The 2005 International Society of Urological Patho‑ logy (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29(9): 1228–1242. 25. Epstein JI. An update of the Gleason grading system. J Urol 2010; 183(2): 433–440. 26. Chen ME, Johnston D, Reyes AO, et al. A streamlined three‑dimensional volume estimation method accurately classifies prostate tumors by volume. Am J Surg Pathol 2003; 27(10): 1291–1301. 27. Carvalhal GF, Humphrey PA, Thorson P, et al. Visual estimate of the percentage of carcinoma is an inde‑ pendent predictor of prostate carcinoma recurrence after radical prostatectomy. Cancer 2000; 89(6): 1308–1314. 28. Pan J, Xue W, Sha J, et al. Incidental prostate cancer at the time of cystectomy: the incidence and clinicopathological features in Chinese patients. PLoS One 2014; 9(4): e94490. 29. Desai A, Wu H, Sun, L, et al. Complete embedding and close step‑sectioning of radical prostatectomy specimens both increase detection of extra‑prostatic extension, and correlate with increased disease‑free survival by stage of prostate cancer patients. Prostate Cancer Prostatic Dis 2002; 5(3): 212–218. 30. Fritsche HM, Aziz A, Eder F, et al. Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens. Virchows Arch 2012; 461(6): 655–661.